You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 13, 2024

List of Excipients in API busulfan


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing busulfan

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Otsuka America Pharmaceutical Inc BUSULFEX busulfan 59148-070 N,N-DIMETHYLACETAMIDE
Otsuka America Pharmaceutical Inc BUSULFEX busulfan 59148-070 POLYETHYLENE GLYCOL 400
Woodward Pharma Services LLC MYLERAN busulfan 69784-620 ANHYDROUS LACTOSE
Woodward Pharma Services LLC MYLERAN busulfan 69784-620 HYPROMELLOSES
Woodward Pharma Services LLC MYLERAN busulfan 69784-620 MAGNESIUM STEARATE
Woodward Pharma Services LLC MYLERAN busulfan 69784-620 STARCH, CORN
Woodward Pharma Services LLC MYLERAN busulfan 69784-620 TITANIUM DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing busulfan

Company Ingredient NDC Excipient
Hospira Inc busulfan 0409-1112 N,N-DIMETHYLACETAMIDE
Hospira Inc busulfan 0409-1112 POLYETHYLENE GLYCOL 400
American Regent Inc busulfan 0517-0920 N,N-DIMETHYLACETAMIDE
American Regent Inc busulfan 0517-0920 POLYETHYLENE GLYCOL 400
Nexus Pharmaceuticals LLC busulfan 14789-013 N,N-DIMETHYLACETAMIDE
Nexus Pharmaceuticals LLC busulfan 14789-013 POLYETHYLENE GLYCOL 400
Accord Healthcare Inc busulfan 16729-351 N,N-DIMETHYLACETAMIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for busulfan

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: N,N-DIMETHYLACETAMIDE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: STARCH, CORN

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group